STOCK TITAN

DaVita Inc. - DVA STOCK NEWS

Welcome to our dedicated page for DaVita news (Ticker: DVA), a resource for investors and traders seeking the latest updates and insights on DaVita stock.

DaVita Inc. (NYSE: DVA) is a leading health care provider focused on transforming care delivery to improve the quality of life for patients globally. With over 20 years of clinical quality and innovation, DaVita is one of the largest providers of kidney care services in the United States. The company operates more than 3,000 dialysis centers globally, serving approximately 250,200 patients, with 2,675 centers in the U.S. and 367 in 11 other countries.

Core Business: DaVita specializes in treating patients with chronic kidney failure and end-stage renal disease. The company provides comprehensive kidney care services, including dialysis treatments, integrated treatment plans, personalized care teams, and convenient health-management services to enhance patients' quality of life.

Recent Achievements: In recent quarters, DaVita has focused on innovation and operational improvements. The company has introduced the Center Without Walls™ (CWOW) platform in collaboration with Google Cloud, leveraging AI and analytics to enhance clinical outcomes. Furthermore, DaVita has integrated its clinical systems to streamline care for its 201,300 patients in the U.S. alone.

Financial Highlights: DaVita reported strong financial performance in 2023, with quarterly and annual growth driven by increased dialysis treatments and improved reimbursement rates. The company has also actively engaged in share repurchases, further solidifying its financial stability.

Partnerships and Projects: DaVita has expanded its international footprint, recently announcing acquisitions in Brazil, Colombia, Chile, and Ecuador. These strategic investments align with DaVita's disciplined growth strategy and aim to enhance its presence in Latin America. Additionally, DaVita has partnered with the American Diabetes Association to tackle chronic disease prevention, particularly focusing on diabetes and kidney disease.

Commitment to Community: DaVita is deeply committed to community well-being, as evidenced by initiatives like the annual Move It With Purpose event, which raised significant funds for the Bridge of Life nonprofit. This event supports global efforts to prevent and treat chronic diseases in underserved communities.

DaVita’s forward-looking initiatives, including investments in integrated kidney care and advanced clinical systems, position the company for sustainable growth and leadership in the health care sector.

Rhea-AI Summary
DaVita Inc. collaborates with Adtalem Global Education to launch the 'Introduction to Nephrology Nursing' curriculum at Chamberlain University, aiming to address the shortage of nurses in the U.S. and provide career pathways in nephrology nursing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
none
-
Rhea-AI Summary
DaVita Inc. to participate in fireside chat with UBS
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
conferences
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.14%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
management
-
Rhea-AI Summary
DaVita Inc. (NYSE: DVA) will hold its quarterly conference call to discuss second quarter results on August 3rd, 2023. The company plans to release its results after market close the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
none
-
Rhea-AI Summary
Cellarity appoints Gregory J. Moore, former Microsoft executive, to its Board of Directors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
management
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.44%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.9%
Tags
none
-
Rhea-AI Summary
DaVita Inc. publishes its 2022 Community Care Report, highlighting progress made towards its 2025 ESG goals. Key milestones include high patient satisfaction ratings, integrated care services, kidney transplants, career pathways program, carbon reduction, renewable energy procurement, volunteer hours, and grants for food insecurity and kidney health education.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.27%
Tags
none

FAQ

What is the current stock price of DaVita (DVA)?

The current stock price of DaVita (DVA) is $169.9 as of January 23, 2025.

What is the market cap of DaVita (DVA)?

The market cap of DaVita (DVA) is approximately 14.7B.

What is DaVita Inc. specialized in?

DaVita Inc. specializes in providing kidney care services, including dialysis treatments for patients with chronic kidney failure and end-stage renal disease.

How many dialysis centers does DaVita operate?

As of December 2023, DaVita operates 3,042 outpatient dialysis centers globally, including 2,675 centers in the United States and 367 in 11 other countries.

What recent technological advancements has DaVita made?

DaVita has introduced the Center Without Walls™ (CWOW) platform in collaboration with Google Cloud, utilizing AI and analytics to improve clinical outcomes.

What are DaVita’s recent achievements?

Recent achievements include strong financial performance in 2023, expansion into Latin America, and strategic partnerships to enhance chronic disease prevention and care.

How does DaVita support its community?

DaVita supports its community through initiatives like the Move It With Purpose event, which raises funds for the Bridge of Life nonprofit to prevent and treat chronic diseases in underserved areas.

Who are DaVita’s key partners?

Key partners include Google Cloud for technological advancements and the American Diabetes Association for chronic disease prevention initiatives.

What financial results did DaVita report in 2023?

DaVita reported strong financial performance with increased dialysis treatments and improved reimbursement rates, alongside active share repurchases, indicating financial stability.

What is DaVita's strategy for international growth?

DaVita’s international growth strategy includes acquisitions in Latin America, enhancing its presence in Brazil, Colombia, Chile, and Ecuador.

What does DaVita’s expansion in Latin America entail?

DaVita’s expansion in Latin America involves acquiring dialysis centers in Brazil, Colombia, Chile, and Ecuador, making it the largest dialysis services provider in the region.

How does DaVita enhance patient care?

DaVita enhances patient care through integrated treatment plans, personalized care teams, and leveraging advanced clinical systems like the CWOW platform.
DaVita Inc.

NYSE:DVA

DVA Rankings

DVA Stock Data

14.71B
42.18M
48.54%
50.31%
4.93%
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States of America
DENVER